Robitussin Maximum Strength Cough

Quick links

Choose a section

Quick links to important sections

Advertisements

Robitussin Maximum Strength Cough

Advertisements
Advertisements

Treatment option: Cough

Advertisements

Overview of Robitussin Maximum Strength Cough

Property Description
Active Ingredient Dextromethorphan Hydrobromide (Dextromethorphan HBr)
Form Oral Solution (Syrup)
Pharmacological Class Antitussive (Cough Suppressant)
Common Use Temporary relief of cough from minor irritation
Origin Synthetic Morphinan Derivative

What Type of Medicine is Robitussin Maximum Strength Cough?

Robitussin Maximum Strength Cough is an over-the-counter (OTC) medication classified as an antitussive or cough suppressant, dedicated to alleviating the cough reflex. Its primary general purpose is the temporary relief of a non-productive cough caused by minor irritation of the throat and bronchi, typically accompanying the common cold or flu. Dextromethorphan HBr, the key component, is a recognized antitussive agent for these symptoms.

Composition and Origin of the Active Ingredient

The composition of this preparation is centered on the single active agent: Dextromethorphan Hydrobromide (Dextromethorphan HBr). Dextromethorphan is a synthetic compound structurally related to the Morphinan chemical class. While its structure bears a similarity to certain opioids, Dextromethorphan HBr is specifically engineered to be non-analgesic and non-addictive when utilized at therapeutic concentrations. The active ingredient is used to reduce cough frequency.

Understanding the Maximum Strength Solution Format

This medicine is presented for the oral route of administration as an oral solution or syrup. The “Maximum Strength” descriptor signifies the product contains a higher concentration of Dextromethorphan HBr per administered dose volume compared to the manufacturer’s standard variants. This formulation's single active ingredient status ensures targeted cough suppression without the inclusion of other components, such as expectorants or decongestants, commonly found in multi-symptom products.

Regulatory References

  1. National Institutes of Health
Advertisements

What side effects are possible with Robitussin Maximum Strength Cough?

Possible side effects and safety information

The safety profile for this medicine, which contains the active ingredient Dextromethorphan Hydrobromide, is defined by regulatory bodies based on documented adverse reactions and specific constraints regarding its use.


Adverse Reaction Scope

Component Description (Regulatory Terminology)
Key Adverse Reaction Categories Central Nervous System effects, Gastrointestinal disturbances, and Hypersensitivity reactions.
Frequency Classification Common reactions include dizziness, drowsiness, nausea, and vomiting. Reactions of the Uncommon or Rare frequency include hypersensitivity.
System-Organ Classes Involved Nervous System Disorders, Gastrointestinal Disorders, and Immune System Disorders.
Serious Adverse Reactions Officially documented serious risks include Serotonin Syndrome (a serious interaction risk, particularly with certain medications), and Respiratory Depression (primarily associated with overdose).

Safety-Related Restrictions and Constraints

Safety-Related Restrictions or Limitations

Regulatory labeling stipulates that the medicine is contraindicated in individuals currently taking a Monoamine Oxidase Inhibitor (MAOI) or who have discontinued an MAOI within the last 14 days. Caution is advised against use for a persistent or chronic cough, such as one resulting from smoking, asthma, or emphysema.

Population-Specific Safety Considerations

Official guidance notes that older adults may exhibit increased sensitivity to the central nervous system effects, such as dizziness and sedation. Individuals with hepatic impairment require particular caution due to the potential for increased drug exposure and toxicity.


Regulatory Safety Summary

The official safety information structures the understanding of the medicine's risk profile by highlighting the expected, frequent central nervous system and gastrointestinal effects, while clearly delineating high-severity risks associated primarily with co-administration and excessive exposure. The explicit safety constraints define the regulatory boundaries for the appropriate use of the active ingredient, Dextromethorphan HBr.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents describe the Dextromethorphan Hydrobromide overdose profile through a cluster of central nervous system (CNS) manifestations. These effects commonly include mental confusion, central excitement, drowsiness, dizziness, and documented instances of hallucinations and nystagmus. Nausea and vomiting are also recognized presentations. Very high doses are associated with an increased risk of severe outcomes.

Overdose may lead to severe, life-threatening physiological consequences. Regulators document the potential for respiratory depression, seizures, and coma. Serious cardiovascular effects, such as tachycardia (fast heart rate) and abnormal ECG findings (QTc prolongation), are also formally associated with severe overdose. Patients with moderate to severe hepatic impairment require specific caution in this context.

Required Emergency Actions

Prompt medical attention is critical for all individuals, including adults and children, even if you do not notice any signs or symptoms immediately following a suspected overdose. The official instruction is to get medical help or contact a Poison Control Center right away. Emergency services must be called if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Management is supportive; this may include monitoring of vital signs and the consideration of Naloxone for respiratory depression by health professionals.

Advertisements

Therapeutic Uses of Robitussin Maximum Strength Cough

This single-agent formulation is generally used to temporarily relieve cough caused by the common cold, the flu, or other irritative conditions. The medication is applicable within clinical settings that involve acute or disruptive symptom patterns of the respiratory system. It is specifically relevant for managing symptoms that create noticeable physiological strain, such as a dry, persistent, non-productive cough which often manifests as an irritating impulse.

This antitussive is used in areas where short-term symptom management is appropriate, particularly for the temporary management of cough due to minor throat irritation, minor bronchial irritation, and cough accompanying the common cold or flu. It provides support that helps ease the overall symptom burden by easing the heightened physiological activity associated with coughing.

This medicine is considered relevant for easing symptoms that interfere with daily comfort, especially when the cough becomes intense enough to interfere with functional stability.

Quick Fact: Relief for Irritating Coughs

Robitussin Maximum Strength is commonly used across conditions characterized by periods of heightened symptoms and supports general well-being by addressing the heightened physiological activity associated with coughing, which assists with maintaining functional stability and can contribute to support for rest for adults and adolescents 12 years of age and over.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Robitussin Maximum Strength Cough

The official eligibility profile for Robitussin Maximum Strength Cough (Dextromethorphan HBr) is determined by governmental regulatory documentation, defining who is approved for use and under what conditions.


Eligibility Scope

Classification Rule (As per Regulatory Label)
Approved Population Adults and children 12 years of age and over.
Prohibited Population Children under 12 years of age must not use this product.
Absolute Contraindication Individuals currently taking a Monoamine Oxidase Inhibitor (MAOI), or who have discontinued an MAOI within the last two weeks.
Conditional Use Patients with a persistent or chronic cough (e.g., due to smoking or asthma), a cough with too much phlegm (mucus), and pregnant or breast-feeding individuals must ask a health professional before use.

Official Eligibility Statements

Regulatory documents define who can and cannot use this medicine by establishing a clear minimum age for unsupervised use and instituting an absolute contraindication based on recent or current use of MAOI drugs. Use is restricted for individuals falling into the conditional-use categories, which necessitates professional consultation prior to administration. The safety and efficacy profile is not established for use in children under 12 years.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation establishes two primary interaction domains for dextromethorphan hydrobromide: enzyme-mediated metabolism and pharmacodynamic effects on the central nervous system.

Formal Contraindications and Restrictions

Classification Interacting Agents Official Restriction and Mechanism
Contraindicated Combination Monoamine Oxidase Inhibitors (MAOIs) Prohibited due to a high risk of serious, potentially fatal Serotonin Syndrome. Co-administration requires a mandatory 14-day separation period (washout) after stopping the MAOI drug.
Exposure-Altering Agents Strong CYP2D6 Inhibitors (e.g., Fluoxetine, Quinidine) Dextromethorphan is a substrate for the CYP2D6 enzyme. These agents are documented to inhibit its clearance, resulting in a clinically significant increase in dextromethorphan plasma concentrations (increased exposure).
Serotonergic Agents SSRIs, SNRIs, Tricyclic Antidepressants Concomitant use with other medicines that increase serotonin levels may lead to additive pharmacodynamic effects, officially increasing the risk of Serotonin Syndrome.
CNS Depressants Alcohol (Ethanol), Narcotic Analgesics Co-administration is officially noted to increase central nervous system (CNS) depressant effects, such as drowsiness and dizziness.

Population-Specific Notes: Individuals classified as CYP2D6 Poor Metabolizers (PMs) are documented to experience significantly higher systemic exposure to the parent drug, which may increase the severity of dose-related side effects and interaction risk.

Advertisements

Mechanism of Action

The pharmacodynamic action of Robitussin Maximum Strength Cough is mediated by its active component, dextromethorphan (DXM), which targets specific central nervous system (CNS) sites. DXM's primary interaction is functioning as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor complex.

This molecular interaction modifies neuronal signaling pathways associated with the reflex arc. The compound further engages the sigma-1 receptor, where it acts as an agonist. This dual-pathway modulation influences the central neural circuits responsible for governing the cough reflex.

The resulting mechanistic cascade involves raising the threshold required for initiating this reflex, which occurs specifically within the medulla oblongata of the brainstem. The system-level physiological consequence of this action is a measurable reduction in the sensitivity of the cough center to afferent signals originating from the peripheral respiratory tract. This modulation is confined to the biochemical and physiological processes governing the neural reflex, with no direct effects on mucosal integrity or secretory function.

Advertisements

Dosage and Administration Information

The instructions for using Robitussin Maximum Strength Cough, a single-agent Dextromethorphan HBr oral solution, establish a framework for administration confined to the oral route. The usage protocol is defined by specific volumetric, frequency, and population constraints.

Administration and Dosing Schedule

The medication is intended for use by adults and children 12 years of age and over, and labeling explicitly prohibits use in children under this minimum age. The dosage regimen is constrained by time and volume.

Administration Parameter Guideline
Standard Single Dose 20 mL (delivering 20 mg Dextromethorphan HBr)
Dosing Frequency Administered every 4 hours as needed
Maximum Daily Limit Not to exceed 6 doses in any 24-hour period (Total 120 mL or 120 mg Dextromethorphan HBr)

Procedural Requirements

The integrity of the dose volume is essential, and instructions require the user to ensure precision by using only the dosing cup provided with the product for accurate measurement. Before dispensing the dose, the solution must be shaken well. The overall use pattern is defined as intermittent and temporary, with the primary procedural constraint being strict adherence to the specified frequency and volume, reinforcing the guideline to not take more than directed. This administration structure defines the scope of the drug's label-based use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Mechanism of Action and Initial Efficacy Studies

Studies have investigated the potential effect of the active ingredient, dextromethorphan (DM), on common cough symptoms associated with the common cold or inhaled irritants. The compound is classified as an antitussive (cough suppressant).

Early-phase trials and subsequent Phase III studies, encompassing over 1,000 subjects, reported that a proportion of participants in the studies experienced an improvement in symptoms. Studies focused on participants experiencing mild to moderate forms of the condition.

Long-Term Outcomes and Safety Profile

One study evaluated whether the active ingredient was associated with a reduction in symptom severity over a 6-month period, but evidence remains limited to this single study. Findings from this specific trial suggested the possibility of longer-term symptom monitoring.

The clinical trials did not report unexpected safety issues in the majority of adult participants. Reported adverse events observed in the study group included drowsiness and digestive upset. The maximum studied dosage used in many large-scale trials for cough suppression in adults is 120 mg per 24 hours.

Comparative Research and Administration

Studies have investigated whether the active ingredient was associated with reduced cough frequency in various populations, including in children aged 6 to 11 years with acute cough due to the common cold. One randomized, placebo-controlled trial found a statistically significant reduction in total coughs over a 24-hour period with dextromethorphan compared to placebo in that group.

Research has evaluated whether taking the compound with food affected absorption. The drug label notes that individuals with a history of liver issues were excluded from or monitored closely in clinical trials. Observed side effects were reported as infrequent; there are no comparative studies that establish one treatment as a better choice.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Robitussin Maximum Strength Cough (FAQ)


Q: How is the 'Maximum Strength' version described compared to regular strength Robitussin products?

According to official product information, the 'Maximum Strength' description signifies that this specific formulation contains a higher concentration of the active ingredient, Dextromethorphan HBr, per dose volume compared to the manufacturer’s standard strength variants.


Q: Does the medicine interact with commonly used non-prescription pain relievers like ibuprofen or acetaminophen?

While the single-ingredient product does not list every non-prescription pain reliever, official labeling notes a caution against combining other medicines that contain acetaminophen (a common pain reliever) with any product that already includes it. This is noted due to the potential risk of severe liver damage associated with excessive acetaminophen exposure.


Q: How long should minor side effects like drowsiness last after a dose?

Regulatory documents confirm that common side effects, such as drowsiness and dizziness, may occur. For the short-acting liquid, the recommended dosing frequency is every four hours, which is consistent with the product's defined duration of activity.


Q: Why is there a reason why people with a cough due to smoking or emphysema should use caution with this product?

Regulatory labeling advises caution when using this product for a persistent or chronic cough, including those associated with smoking or conditions like emphysema or asthma. For these specific, ongoing conditions, official guidelines state that mathbfconsultation with a health professional is necessary before use for these specific conditions.


Q: Are there warnings about combining this medicine with other products that also cause drowsiness?

Yes, official warnings note that combining this medication with other central nervous system (CNS) depressants, such as alcohol or narcotic analgesics, is associated with increased CNS effects. These additive effects can potentially increase experiences of drowsiness and dizziness.


Q: What are the key signs that suggest a person should stop using the product and seek professional advice?

Official labeling details specific criteria for discontinuing use and contacting a health professional. These criteria include if mathbfnervousness, dizziness, or sleeplessness occur, if the cough mathbfworsens or lasts more than 7 days, or if the cough returns alongside a mathbffever, rash, or persistent headache.


Q: How long are the cough relief effects of the dose expected to last?

The duration of cough relief is indicated by the standard dosing schedule found in the official instructions. For the liquid formulation, a single dose is intended for temporary relief, and the defined mathbfdosing interval is every 4 hours as needed.


Q: Is the 12-hour extended-release formulation functionally different from the standard liquid formula?

Yes, the primary functional difference relates to the duration of the effect. Standard liquid syrups are short-acting and are typically dosed every four hours, whereas extended-release products are formulated for sustained release, allowing them to be dosed every mathbf12 hours.


Q: Can taking this medicine cause a feeling of confusion, anxiety, or nervousness?

Official safety information includes mathbfnervousness as a symptom that requires the user to stop the medication and consult a health professional. Other mental or neurological changes, such as mathbfconfusion, are documented in official adverse event reporting associated with serious reactions or excessive exposure.


Q: Does the medicine have any documented effects on a person's blood pressure?

When Dextromethorphan is formulated with other ingredients, such as decongestants, official labeling for those combination products may include specific warnings. These warnings indicate that individuals with pre-existing conditions like mathbfhigh blood pressure should consult a health professional prior to use.


Q: Does Robitussin Maximum Strength Cough contain alcohol?

The inactive ingredients, including alcohol content, can vary significantly depending on the specific flavor and formulation. Official labeling confirms that some Dextromethorphan liquid products are explicitly designated as mathbfalcohol-free. Consulting the inactive ingredient list on the specific product packaging provides definitive information.


Q: Is Robitussin Maximum Strength Cough intended for use with flu symptoms or only the common cold?

Yes, official drug information indicates that the active ingredient, Dextromethorphan, is intended for the temporary relief of cough caused by minor throat and bronchial irritation associated with both the mathbfcommon cold and the mathbfflu.


Q: What is the main difference between extended-release formulations and liquid syrups?

The main difference between the two forms is the way the active ingredient is released in the body. Liquid syrups are short-acting, consistent with the typical four-hour dosing interval, while extended-release formulations are designed for mathbfsustained release, which allows for dosing every mathbf12 hours.


Q: Why do official documents recommend consulting a health professional if a cough lasts more than 7 days?

Official labeling directs users to consult a health professional if the cough mathbflasts for more than 7 days, worsens, or tends to recur. This caution is advised because a persistent or recurring cough may be an indicator of a more serious underlying medical condition that requires specific diagnosis and treatment.


Q: Are there research studies or evidence themes that examine the cough-suppressant effects of Dextromethorphan?

Regulatory overviews and research summaries confirm that studies have mathbfinvestigated the potential effect of Dextromethorphan on common cough symptoms. The compound is officially classified as an mathbfantitussive, which is the pharmacological term for a cough suppressant.


Q: What is the difference between a cough suppressant like Dextromethorphan and products containing codeine?

Dextromethorphan is a synthetic compound structurally related to the morphinan chemical class, which includes codeine. However, Dextromethorphan is specifically engineered to be mathbfnon-analgesic (not a pain reliever) and described as mathbfnon-addictive when used at therapeutic concentrations. In contrast, codeine is an mathbfopioid analgesic and is regulated differently, often requiring a prescription.


Q: Is it necessary to take this medicine with food, or can it be taken on an empty stomach?

Regulatory information for Dextromethorphan formulations indicates that the product can typically be administered mathbfwithout regard for the timing of meals. This means that the product can be taken either on an empty stomach or with food.


Advertisements

How should Robitussin Maximum Strength Cough be stored and disposed of?

How to Store and Dispose of Robitussin Maximum Strength Cough

To maintain the product's quality, store Robitussin Maximum Strength Cough liquid at controlled room temperature, specifically between 20°C and 25°C (68°F and 77°F).

Crucially, the medication must be protected from both freezing and excessive heat or moisture. Store the bottle in its original container with the cap tightly closed, placing it in a location that is out of the sight and reach of children and pets.

When disposing of unused or expired medication, do not flush it down a toilet or pour it into a drain. Instead, properly discard the product, consulting a pharmacist or local waste disposal company for guidance on medication take-back programs or household disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Robitussin Maximum Strength Cough found in:

A-Z Index: